PMID: 8959948Dec 1, 1996Paper

Chronic telogen effluvium: increased scalp hair shedding in middle-aged women

Journal of the American Academy of Dermatology
D A Whiting

Abstract

Diffuse loss of scalp hair is a common problem in middle-aged women. A segment of these cases represents idiopathic chronic telogen effluvium (CTE). The purpose was to establish distinctive clinical and pathologic criteria for the diagnosis of CTE to facilitate its differentiation from androgenetic alopecia (AGA) and systemic causes of chronic diffuse hair loss. A group of 355 patients (346 females, 9 males) with diffuse generalized thinning of scalp hair of unknown origin were classified as having CTE and were included in the study. Characteristically they presented with a history of hair loss with both increased shedding and thinning of abrupt onset and fluctuating course and showed diffuse thinning of hair all over the scalp, frequently accompanied by bitemporal recession. Two 4 mm punch biopsy specimens were taken mostly from the mid or posterior parietal scalp of these patients. The biopsies were performed at these same areas in 412 patients with AGA (193 male, 219 female). Similar paired biopsy specimens were also taken from 22 normal control subjects (13 males, nine females). Specimens were sectioned horizontally and vertically and were examined for terminal and velluslike (miniaturized) hairs, follicular stelae, follicu...Continue Reading

References

Jun 14, 1976·JAMA : the Journal of the American Medical Association·D K Goette, R B Odom
Jul 1, 1991·Journal of the American Academy of Dermatology·L C Sperling
Jun 1, 1990·The British Journal of Dermatology·R PausR E Link
Aug 1, 1990·The British Journal of Dermatology·D H RushtonJ J Gilkes
Sep 1, 1972·Archives of Dermatology·R K Freinkel, N Freinkel
Mar 1, 1993·Archives of Dermatology·J T Headington
Feb 1, 1961·Archives of Dermatology·A M KLIGMAN

❮ Previous
Next ❯

Citations

Jun 9, 2001·Clinics in Dermatology·D A Whiting
Feb 15, 2001·Clinics in Dermatology·A S Al-Fouzan, A Nanda
Jul 17, 2001·The British Journal of Dermatology·J H PaikN I Kim
Aug 23, 2002·Clinical and Experimental Dermatology·S Harrison, R Sinclair
Aug 23, 2002·Clinical and Experimental Dermatology·M P BirchA G Messenger
Sep 10, 1998·International Journal of Dermatology·D A Whiting
Sep 6, 2000·International Journal of Dermatology·Y F MahéB A Bernard
Aug 5, 2003·The Journal of Investigative Dermatology. Symposium Proceedings·Vera H Price
Aug 5, 2003·The Journal of Investigative Dermatology. Symposium Proceedings·Rodney SinclairDavid Whiting
Aug 5, 2003·The Journal of Investigative Dermatology. Symposium Proceedings·Rie UekiHideoki Ogawa
Oct 19, 2007·The New England Journal of Medicine·Jerry Shapiro
Jun 17, 2006·The American Journal of Dermatopathology·Klaus Sellheyer, Wilma F Bergfeld
Dec 5, 1998·The Australasian Journal of Dermatology·J R Sullivan, S Kossard
Dec 1, 2006·Journal of Cosmetic Dermatology·A TostiS Voudouris
Feb 21, 2004·Skin Pharmacology and Physiology·G E PiérardUNKNOWN EEMCO group (European Expert Group on Efficacy Measurement of Cosmetics and other Topical Products)
Mar 1, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·Amadé Bregy, Ralph M Trueb
Aug 13, 2011·Clinical, Cosmetic and Investigational Dermatology·Katherine A Gordon, Antonella Tosti
Jan 1, 2008·Indian Journal of Dermatology·Javidi ZariNahidi Yalda
Apr 11, 2014·International Journal of Endocrinology and Metabolism·Ingrid Herskovitz, Antonella Tosti
Aug 27, 2013·Indian Journal of Dermatology, Venereology and Leprology·Chander Grover, Ananta Khurana
Dec 15, 2010·Clinics in Dermatology·David A Whiting
Oct 16, 2010·Journal of the American Academy of Dermatology·Elise A OlsenLeslie Caudill
Dec 30, 2015·International Journal of Dermatology·Caroline BittencourtMaria L Cintra
Nov 26, 2009·The Medical Clinics of North America·Shannon Harrison, Wilma F Bergfeld
Apr 4, 2009·Seminars in Cutaneous Medicine and Surgery·Francisco M Camacho-Martínez
Sep 14, 2007·The Journal of Investigative Dermatology·Jiang ChenDennis R Roop
Oct 18, 2015·The Medical Clinics of North America·Jay C Vary
Jul 12, 2008·Journal of Cutaneous Pathology·Marcelo G Horenstein, Jack S Jacob
Nov 7, 2006·Journal of Cutaneous Pathology·J Andrew CarlsonJoseph Schwartz
Oct 13, 2006·The British Journal of Dermatology·A G Messenger, R Sinclair
Dec 30, 2011·The British Journal of Dermatology·A G Messenger
Aug 11, 2010·The Australasian Journal of Dermatology·Stephen Gilmore, Rodney Sinclair
Jan 9, 2010·Histopathology·Catherine M Stefanato
Apr 14, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·W ChenJ Ring
Jan 13, 2015·Journal of Cosmetic Dermatology·Caroline Le Floc'hAntonella Tosti
Apr 26, 2006·Journal of the American Academy of Dermatology·Elise A Olsen
Oct 1, 1996·Dermatologic Clinics·D A Whiting
May 13, 2005·The British Journal of Dermatology·A TostiC Misciali
Mar 25, 2005·The British Journal of Dermatology·R SinclairD Jolley
Jun 16, 2009·Clinical and Experimental Dermatology·K A GiehlJ P Sundberg
May 24, 2012·Journal of Cutaneous Pathology·Mariya MitevaAntonella Tosti
Aug 26, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·T R EkmekciA Koslu
Jan 29, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Ralph M Trüeb

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.